Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.

Nonaka D, Chiriboga L, Soslow RA.

Am J Surg Pathol. 2008 Oct;32(10):1566-71. doi: 10.1097/PAS.0b013e31816d71ad.

PMID:
18724243
2.

Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.

Corben AD, Nehhozina T, Garg K, Vallejo CE, Brogi E.

Am J Surg Pathol. 2010 Aug;34(8):1211-6. doi: 10.1097/PAS.0b013e3181e5e03e. Review.

PMID:
20631604
3.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
4.

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

McCluggage WG.

Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Review.

PMID:
21716157
5.

Histologic subtypes of ovarian carcinoma: an overview.

Soslow RA.

Int J Gynecol Pathol. 2008 Apr;27(2):161-74. doi: 10.1097/PGP.0b013e31815ea812. Review.

PMID:
18317227
6.

Serous carcinoma of the ovary with squamous differentiation: a case report and a literature review.

Roberts DE, Lombard CM.

Int J Gynecol Pathol. 2013 Sep;32(5):459-63. doi: 10.1097/PGP.0b013e31826f0327. Review.

PMID:
23896710
7.

Value of PAX 8 immunostaining in tumor diagnosis: a review and update.

Ordóñez NG.

Adv Anat Pathol. 2012 May;19(3):140-51. doi: 10.1097/PAP.0b013e318253465d. Review.

PMID:
22498579
8.

Evaluation of PAX8 Expression in Brain Tissue and Related Neoplasms.

Khanlou N, Shintaku P, Yi J, Moatamed NA.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):207-9. doi: 10.1097/PAI.0000000000000192. Review.

PMID:
26371431
9.

Renal dysplasia.

Chen RY, Chang H.

Arch Pathol Lab Med. 2015 Apr;139(4):547-51. doi: 10.5858/arpa.2013-0660-RS. Review.

PMID:
25822765

Supplemental Content

Support Center